Lumoxiti الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

lumoxiti

astrazeneca ab - moxetumomab pasudotox - hvítblæði, hairy cell - Æxlishemjandi lyf - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).

Dexól Saft 3 mg/ml أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

dexól saft 3 mg/ml

laboratoria qualiphar - dextromethorphanum hýdróbrómíð mónóhýdrat - saft - 3 mg/ml

Aranesp الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

aranesp

amgen europe b.v. - darbepoetin alfa - anemia; cancer; kidney failure, chronic - Önnur antianemic undirbúningur - meðferð við blóðleysi með einkennum í tengslum við langvarandi nýrnabilun (crf) hjá fullorðnum og börnum. meðferð einkennum blóðleysi í fullorðinn krabbamein sjúklinga með ekki-merg illkynja fá lyfjameðferð.

Eqvalan vet. Pasta til inntöku 1,87 % أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

eqvalan vet. pasta til inntöku 1,87 %

boehringer ingelheim animal health france scs - ivermectinum inn - pasta til inntöku - 1,87 %